TAYSHA GENE THERAPIES INC (TSHA) Institutional Ownership and Insiders Activity

TAYSHA GENE THERAPIES INC (TSHA) is widely held by institutional investors, with 205 firms reporting positions valued at approximately $2.04B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Avoro Capital Advisors Llc is the largest disclosed holder, reporting approximately $162.68M in TSHA holdings in its latest filing.

Recent insider activity includes 1 tracked Form 4 transaction over the last three months, reflecting ongoing executive and director trading activity.